Cargando…

Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study

BACKGROUND: HIV infection is associated with significant neurocognitive deficits making maximization of cognitive function among children receiving antiretroviral therapy (ART) a public health imperative. Non-protease inhibitors (non-PIs) achieve higher drug levels in the cerebral spinal fluid (CSF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nalwanga, Damalie, Musiime, Victor, Bangirana, Paul, Nishiguchi, Erika Phelps, Kiggwe, Andrew, Ssesanga, Titus, Ssenkusu, John M., Musoke, Philippa, Cusick, Sarah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073947/
https://www.ncbi.nlm.nih.gov/pubmed/33902506
http://dx.doi.org/10.1186/s12887-021-02676-2
_version_ 1783684246243639296
author Nalwanga, Damalie
Musiime, Victor
Bangirana, Paul
Nishiguchi, Erika Phelps
Kiggwe, Andrew
Ssesanga, Titus
Ssenkusu, John M.
Musoke, Philippa
Cusick, Sarah E.
author_facet Nalwanga, Damalie
Musiime, Victor
Bangirana, Paul
Nishiguchi, Erika Phelps
Kiggwe, Andrew
Ssesanga, Titus
Ssenkusu, John M.
Musoke, Philippa
Cusick, Sarah E.
author_sort Nalwanga, Damalie
collection PubMed
description BACKGROUND: HIV infection is associated with significant neurocognitive deficits making maximization of cognitive function among children receiving antiretroviral therapy (ART) a public health imperative. Non-protease inhibitors (non-PIs) achieve higher drug levels in the cerebral spinal fluid (CSF) compared to PIs, potentially leading to better neurocognitive function by reducing CSF viral load and inflammation. ART that maximises children’s neurodevelopment and school achievement could result in improved quality of life and productivity as adults, but little research to date has examined whether non-PI ART is associated with better neurocognitive outcomes. We compared the neurocognitive function between children living with HIV receiving PI-based and non PI-based ART. METHODS: We recruited a consecutive sample of clinically stable Ugandan children living with HIV aged 5–12 years who received PI-based or non PI-based ART for ≥ 1 year (viral load < 1000 copies). Neurocognitive function was assessed using the Kaufman Assessment Battery for Children, the Test of Variables of Attention, and Bruininks-Oseretsky Test of Motor Proficiency. Age-adjusted neurocognitive z-scores for the two groups were compared using linear regression models in STATA version 13. The Hommel’s method was used to adjust for multiple testing. RESULTS: We enrolled 76 children living with HIV; 34 on PI ART and 42 on non-PI ART. Mean (±SD) age was greater in the non-PI vs. PI group (9.5 ± 1.9 vs. 8.5 ± 2.0) years (p = 0.03). Children in the non-PI group had lower socioeconomic scores (5.7 ± 3.3 vs. 7.4 ± 2.8, p = 0.02). There was no difference in neurocognitive function between the groups (adjusted p > 0.05) for KABC and TOVA. Children in the PI group had better total BOT scores than their counterparts (46.07 ± 1.40) vs. 40.51 (1.24), p = 0.03). CONCLUSIONS: We detected no difference in neurocognitive function among children on PI and non PI-based ART therapy based on KABC and TOVA tests. Children on PI based ART had better motor function than their counterparts. We recommend a prospective study with a larger sample size. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-021-02676-2.
format Online
Article
Text
id pubmed-8073947
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80739472021-04-26 Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study Nalwanga, Damalie Musiime, Victor Bangirana, Paul Nishiguchi, Erika Phelps Kiggwe, Andrew Ssesanga, Titus Ssenkusu, John M. Musoke, Philippa Cusick, Sarah E. BMC Pediatr Research Article BACKGROUND: HIV infection is associated with significant neurocognitive deficits making maximization of cognitive function among children receiving antiretroviral therapy (ART) a public health imperative. Non-protease inhibitors (non-PIs) achieve higher drug levels in the cerebral spinal fluid (CSF) compared to PIs, potentially leading to better neurocognitive function by reducing CSF viral load and inflammation. ART that maximises children’s neurodevelopment and school achievement could result in improved quality of life and productivity as adults, but little research to date has examined whether non-PI ART is associated with better neurocognitive outcomes. We compared the neurocognitive function between children living with HIV receiving PI-based and non PI-based ART. METHODS: We recruited a consecutive sample of clinically stable Ugandan children living with HIV aged 5–12 years who received PI-based or non PI-based ART for ≥ 1 year (viral load < 1000 copies). Neurocognitive function was assessed using the Kaufman Assessment Battery for Children, the Test of Variables of Attention, and Bruininks-Oseretsky Test of Motor Proficiency. Age-adjusted neurocognitive z-scores for the two groups were compared using linear regression models in STATA version 13. The Hommel’s method was used to adjust for multiple testing. RESULTS: We enrolled 76 children living with HIV; 34 on PI ART and 42 on non-PI ART. Mean (±SD) age was greater in the non-PI vs. PI group (9.5 ± 1.9 vs. 8.5 ± 2.0) years (p = 0.03). Children in the non-PI group had lower socioeconomic scores (5.7 ± 3.3 vs. 7.4 ± 2.8, p = 0.02). There was no difference in neurocognitive function between the groups (adjusted p > 0.05) for KABC and TOVA. Children in the PI group had better total BOT scores than their counterparts (46.07 ± 1.40) vs. 40.51 (1.24), p = 0.03). CONCLUSIONS: We detected no difference in neurocognitive function among children on PI and non PI-based ART therapy based on KABC and TOVA tests. Children on PI based ART had better motor function than their counterparts. We recommend a prospective study with a larger sample size. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-021-02676-2. BioMed Central 2021-04-26 /pmc/articles/PMC8073947/ /pubmed/33902506 http://dx.doi.org/10.1186/s12887-021-02676-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Nalwanga, Damalie
Musiime, Victor
Bangirana, Paul
Nishiguchi, Erika Phelps
Kiggwe, Andrew
Ssesanga, Titus
Ssenkusu, John M.
Musoke, Philippa
Cusick, Sarah E.
Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study
title Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study
title_full Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study
title_fullStr Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study
title_full_unstemmed Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study
title_short Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study
title_sort neurocognitive function among hiv-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in uganda: a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073947/
https://www.ncbi.nlm.nih.gov/pubmed/33902506
http://dx.doi.org/10.1186/s12887-021-02676-2
work_keys_str_mv AT nalwangadamalie neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy
AT musiimevictor neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy
AT bangiranapaul neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy
AT nishiguchierikaphelps neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy
AT kiggweandrew neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy
AT ssesangatitus neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy
AT ssenkusujohnm neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy
AT musokephilippa neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy
AT cusicksarahe neurocognitivefunctionamonghivinfectedchildrenonproteaseinhibitorbasedversusnonproteaseinhibitorbasedantiretroviraltherapyinugandaapilotstudy